LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p.

Abstract

INTRODUCTION:

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with a poor response to chemotherapy and an extremely poor prognosis. Recent studies have revealed that phospholysine phosphohistidine inorganic pyrophosphate phosphatase (LHPP) can inhibit the growth of various cancers. Therefore, the current study was conducted to investigate the antitumor effects of LHPP in PDAC and to explore its mechanism using proteomics analysis.

METHODS AND RESULTS:

Immunohistochemical analysis of clinical samples demonstrated that LHPP expression levels were lower in tumor tissues compared to adjacent nontumor tissues. Moreover, multivariate COX regression analysis showed that LHPP expression level was an independent prognostic factor for the patients with PDAC. Patients with high LHPP expression had a better prognosis. The lentiviral vectors for normal control (NC), LHPP knockdown (KD), and LHPP overexpression (OE) were infected with BxPC-3 and PANC-1 cell lines. Cell counting kit-8 assay, Transwell assay, and flow cytometry analyses showed that LHPP overexpression significantly inhibited the cell viability, migration, and proliferation of BxPC-3 and PANC-1 cells. Moreover, xenograft tumor model demonstrated that LHPP overexpression inhibited xenograft tumor growth in vivo. Subsequently, proteins with significantly altered expression in BxPC-3 cells after lentivirus infection were detected using proteomics analyses. Interestingly, compared to the NC group, the expression of Syndecan 1 (SDC1) was significantly upregulated in the KD group, while that of S100P was significantly downregulated in the OE group.

CONCLUSION:

LHPP might emerge as an important target for delaying the advancement of PDAC, thereby providing a novel therapeutic approach for the treatment of PDAC.

• Authors: Zhaozhi Xia, Shuchao Zhao, Xin Gao, Hongrui Sun, Faji Yang, Huaqiang Zhu, Hengjun Gao, Jun Lu, Xu Zhou
• Journal: Technology in cancer research & treatment (Technol Cancer Res Treat) 2023 Jan-Dec Vol. 22 Pg. 15330338231177807 ISSN: 1533-0338 [Electronic] United States
• PMID: 37321804 (Publication Type: Journal Article)

Chemical References

• SDC1 protein, human
• Syndecan-1
• phospholysine phosphohistidine inorganic pyrophosphate phosphatase, human

Topics

• Humans
• Carcinoma, Pancreatic Ductal (genetics, metabolism)
• Cell Line, Tumor
• Cell Proliferation (genetics)
• Pancreatic Neoplasms (pathology)
• Syndecan-1